Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 1 min

Systemic sarcoidosis with neurosarcoidosis presenting with pulmonary embolism, epileptic seizures, and neuropsychiatric involvement in a patient with pre-existing schizophrenia: a diagnostic challenge

AI Summary
  • Neurosarcoidosis may mimic primary psychiatric illness, delaying diagnosis when new neuropsychiatric symptoms arise in patients with existing psychiatric disorders.
  • Diagnosis required biopsy confirmed systemic sarcoidosis, CSF intrathecal immune response, EEG showing left temporal epileptiform seizures, and leptomeningeal MRI changes.
  • High-dose corticosteroids with antiseizure therapy produced marked clinical improvement and reported resolution of MRI abnormalities.
Summarise with AI (MRCPsych/FRANZCP)

Acta Neurol Belg. 2026 Nov 11. doi: 10.1007/s13760-026-03232-4. Online ahead of print.

ABSTRACT

Neurosarcoidosis affects approximately 5-10% of patients with systemic sarcoidosis and may mimic primary psychiatric disease, delaying diagnosis. We report a 52-year-old man with pre-existing schizophrenia admitted with bilateral pulmonary embolism and mediastinal lymphadenopathy. Systemic sarcoidosis was confirmed by endobronchial ultrasound-guided lymph node biopsy and gastric histology. The patient subsequently developed epileptic seizures and a progressive neuropsychiatric syndrome initially attributed to his known psychiatric disorder. Electroencephalography demonstrated diffuse slowing with abundant epileptiform discharges and electro-clinical seizures of left temporal onset; brain MRI showed leptomeningeal involvement with cortical diffusion restriction; cerebrospinal fluid excluded infectious causes and showed an intrathecal immune response. A diagnosis of probable neurosarcoidosis was established, although a seizure-related contribution to the MRI findings could not be excluded. Treatment with high-dose corticosteroids and antiseizure medication was followed by marked clinical improvement and reported resolution of the MRI abnormalities. This case underscores the importance of considering neurosarcoidosis in patients with systemic granulomatous disease who develop new neuropsychiatric symptoms, even when a pre-existing psychiatric diagnosis offers an apparently sufficient explanation.

PMID:43012916 | DOI:10.1007/s13760-026-03232-4

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD